These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3263156)

  • 21. Novel compositions of emulsified perfluorochemicals for biological uses.
    Sharma SK; Lowe KC; Davis SS
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):447-50. PubMed ID: 3179481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influences of Fluosol-DA infusion on the complement activation and on the blood level of histamine in man].
    Fukushima K; Nakamura M; Hinuma K
    Masui; 1983 Feb; 32(2):192-8. PubMed ID: 6854932
    [No Abstract]   [Full Text] [Related]  

  • 23. Compatibility of different colloid plasma expanders with perflubron emulsion: an intravital microscopic study in the hamster.
    Nolte D; Pickelmann S; Lang M; Keipert P; Messmer K
    Anesthesiology; 2000 Nov; 93(5):1261-70. PubMed ID: 11046215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma-mediated alterations of erythrocyte deformability by perfluorochemical blood substitutes.
    Holloway GM; O'Rear EA; Fung BM
    Blood; 1986 Jan; 67(1):173-6. PubMed ID: 3940545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of fluorocarbon emulsions in cancer radiotherapy.
    Guichard M
    Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A screening test for modified hemoglobin blood substitutes before clinical use: based on C3a complement activation in human plasma.
    Chang TM; Lister C
    Biomater Artif Cells Artif Organs; 1990; 18(5):693-701. PubMed ID: 2099226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunomodulating properties of perfluorocarbon emulsions].
    Smelova OS; Donskov SI; Afonin NI; Klinova EG; Krasavtseva TK
    Gematol Transfuziol; 1988 Oct; 33(10):33-7. PubMed ID: 3215457
    [No Abstract]   [Full Text] [Related]  

  • 28. Perfluorocarbon emulsions and cardiopulmonary bypass: a technique for the future.
    Spiess BD; Cochran RP
    J Cardiothorac Vasc Anesth; 1996 Jan; 10(1):83-89; quiz 89-90. PubMed ID: 8634391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of methylprednisolone, prednisolone and dexamethasone on granulocyte function and complement activation.
    Redl H; Lamche H; Paul E; Schiesser A; Schlag G
    Prog Clin Biol Res; 1987; 236B():261-72. PubMed ID: 2441413
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of homologous and heterologous stroma-free hemoglobin and polyhemoglobin on complement activation, leucocytes and platelets.
    Ning J; Chang TM
    Biomater Artif Cells Artif Organs; 1990; 18(2):219-32. PubMed ID: 2369648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of different emulsifiers on biocompatibility and inflammatory potential of Perfluorohexyloctane (F6H8) emulsions for new intravenous drug delivery systems.
    Tsagogiorgas C; Anger F; Beck G; Breedijk A; Yard B; Hoeger S
    Drug Des Devel Ther; 2019; 13():2097-2110. PubMed ID: 31417241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental studies of the influence of priming solutions on the systemic activation of complement during cardiopulmonary bypass: comparison between the use of albumin, hydroxyethyl starch and HWA-138.
    Bunk A; Dapper F; Hata H; Neuhof H; Hehrlein FW
    J Cardiovasc Surg (Torino); 1993 Apr; 34(2):115-22. PubMed ID: 7686550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents.
    Dawson P; Turner MW; Bradshaw A; Westaby S
    Br J Radiol; 1983 Jul; 56(667):447-8. PubMed ID: 6602640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Red blood cell substitutes and artificial blood.
    Bowman RJ
    Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorocarbon-based in vivo oxygen transport and delivery systems.
    Riess JG
    Vox Sang; 1991; 61(4):225-39. PubMed ID: 1776239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of perfluorotributylamine/pluronic F-68 stem-emulsion (FC43se) against reperfusion injury in ischemic rabbit lungs.
    Ueno T; Matsuura Y; Wada S; Murakami H; Kajihara H
    Transplant Proc; 1997; 29(1-2):1349-53. PubMed ID: 9123336
    [No Abstract]   [Full Text] [Related]  

  • 37. Improving emulsification efficacy of lecithin by formulation design. I: Effect of adding a secondary surfactant.
    Krishna G; Wood GC; Sheth BB
    PDA J Pharm Sci Technol; 1998; 52(6):331-6. PubMed ID: 10050132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
    Tremper KK; Anderson ST
    Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of the human lymphoid Raji-line cell culture in tests of the toxicity of perfluorocarbon emulsions and their separate components].
    Arkhipov VV; Narimanov AA
    Farmakol Toksikol; 1984; 47(5):117-20. PubMed ID: 6500028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiography and complement activation. Evidence for generation of C3a anaphylatoxin by intravascular contrast agents.
    Westaby S; Dawson P; Turner MW; Pridie RB
    Cardiovasc Res; 1985 Feb; 19(2):85-8. PubMed ID: 3872180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.